Identification of plasma antibody epitopes and gene abnormalities in Japanese hemophilia a patients with factor VIII inhibitor

スポンサーリンク

概要

• 論文の詳細を見る
• 名古屋大学の論文

著者

• 小嶋 哲人

  Department Of Transfusion Medicine Cardiology And Hematology Nagoya University Hospital

• 小嶋 哲人

  名古屋大学医学部第一内科

• 小嶋 哲人

  名古屋大学 保健

• Saito H

  Department Of Hematology Meitetsu Hospital

• Hiraoka Sakamaki

  Department Of Hematology Tokyo Metropolitan Komagome Hospital

• YAMAMOTO Koji

  Division of Transfusion Medicine, Nagoya University Hospital

• Kojima Tetsuhito

  名古屋市立大学 医学系研究科血液腫瘍内科学

• Sao Hiroshi

  Department Of Hematology Hamamatsu Medical Center

• KOJIMA Tetsuhito

  First Department of Internal Medicine, Nagoya University School of Medicine

• SAITO Hidehiko

  First Department of Internal Medicine, Nagoya University School of Medicine

• Saito H

  Nagoya Central Hospital

• Soda Hisashi

  Department Of Hematology Tokyo Metropolitan Komagome Hospital

• Soda Hisashi

  Department Of Internal Medicine Isahaya Insurance General Hospital

• KAMIYA Tadashi

  Japanese Red Cross Aichi Blood Center

• Saito Hidehiko

  First Department Of Internal Medicine Nagoya University School Of Medicine

• OKAMOTO Yoshihiro

  First Department of Internal Medicine, Nagoya University School of Medicine, Department of Clinical

• Saito H

  Nagoya National Hospital

• Kojima Tetsuhito

  First Department First Department Of Internal Medicine Nagoya University School Of Medicine:departme

• MATSUSHITA Tadashi

  First Department of Internal Medicine, Nagoya University School of Medicine

• Sugihara Takuro

  Department of Internal Medicine, Hekinan City Hospital, First Department of Internal Medicine, Nagoy

• Takahashi Isao

  Japanese Red Cross Aichi Blood Center

• Yamamoto Koji

  First Department of Internal Medicine, Nagoya University School of Medicine

• Yamamoto Koji

  Division Of Transfusion Medicine Nagoya University Hospital

• Okamoto Yoshihiro

  First Department Of Internal Medicine Nagoya University School Of Medicine

• Takahashi Isao

  Division Of Oncology And Hematology National Cancer Center Hospital East

• Sugihara Takuro

  Department Of Internal Medicine Hekinan City Hospital First Department Of Internal Medicine Nagoya U

• SUGIHARA Takuro

  Department of Hematology, Hekinan Municipal Hospital

関連論文

• A SIMPLE AND SELECTIVE HPLC METHOD FOR THE SIMULTANEOUS DETERMINATION OF PARAQUAT AND DIQUAT IN HUMAN URINE
• Allogeneic stem cell transplantation versus chemotherapy as post-remission therapy for intermediate or poor risk adult acute myeloid leukemia : results of the JALSG AML97 study
• 日本人の血栓性素因
• 白血病細胞株を用いた巨核芽球系分化誘導モデルにおけるヒトスフィンゴシンキナーゼ1発現機序の解析
• Long-PCR 法を用いた血液凝固第 VIII 因子 遺伝子の逆位解析
• 尿中HIV抗体検査の臨床的有用性に関する研究-全国11施設による協同研究-
• プロテイン S 欠乏症
• Phase II study of tacrolimus and methotrexate for prophylaxis of acute graft-versus-host disease after HLA-A, B, and DRB1 genotypically mismatched unrelated bone marrow transplantation among Japanese patients
• 原因不明の出血を初発症状とし,心症状が進行性に出現し死亡した71歳男性
• Activated protein C resistance in the Japanese population due to homozygosity for the factor V R2 haplotype
• Outcome of allogeneic bone marrow transplantation from unrelated donors for adult Philadelphia chromosome-negative acute lymphocytic leukemia in first complete-remission
• Successful treatment of relapsed T-cell non-Hodgkin's lymphoma with allogeneic peripheral blood stem cell transplantation with double conditioning
• Expression of the Wilms' Tumor Gene WT1 in Solid Tumors and Its Involvement in Tumor Cell Growth
• Peripheral blood stem cell versus bone marrow transplantation from HLA-identical sibling donors in patients with leukemia : a propensity score-based comparison from the Japan Society for Hematopoietic Stem Cell Transplantation registry
• Chronic Graft-versus-Host Disease following Varicella-Zoster Virus Infection in Allogeneic Stem Cell Transplant Recipients
• Stress-induced PAI-1 expression is suppressed by pitavastatin in vivo
• Definite diagnosis in Japanese patients with protein C deficiency by identification of causative PROC mutations
• Mutational analysis of SOS1 gene in acute myeloid leukemia
• Identification of amino acid residues responsible for von Willebrand factor binding to sulfatide by charged-to-alanine-scanning mutagenesis
• Hematopoietic stem cell transplantation for acute promyelocytic leukemia in second or third complete remission : a retrospective analysis in the Nagoya Blood and Marrow Transplantation Group
• Wilms' tumor 1 message and protein expression in bone marrow failure syndrome and acute leukemia
• Mutated RAS Induced PLD1 Gene Expression through Increased Sp1 Trascription Factor
• Recurrent Mutations of Factor XI Gene in Japanese
• Structural Organization and Promoter Activity of the Human Ryudocan Gene
• シンポジウム3 血栓症への新しいアフローチ血栓症の分子細胞学的基礎-プロテインC, プロテインS欠損症を例として-
• プロテインC-Nagoyaにおける分泌異常の解析
• 日本人血友病BのDNAポリモルフィズムを用いた保因者ならびに出生前遺伝子診断
• 第VIII因子遺伝子逆位解析の重症血友病Aにおける保因者診断, 出生前診断への応用
• ジーンターゲティングを用いた血液凝固制御因子の生体における機能解明 : マウスantithrombinの完全欠損による胎児死亡とsyndecan-4欠損による胎盤迷路層胎児血管の変性
• Recurrent Intramural Hematoma of the Small Intestine in a Severe Hemophilia A Patient with a High Titer of Factor VIII Inhibitor : A Case Report and Review of the Literature
• High Titer of ADAMTS13 Inhibitor Associated with Thrombotic Microangiopathy of the Gut and Skeletal Muscle after Allogeneic Hematopoietic Stem Cell Transplantation
• ヒトRyudocan分子の精製と生物学的機能解析
• Clinical Trial to Investigate the Pharmacokinetics, Pharmacodynamics, Safety, and Efficacy of Recombinant Factor VIIa in Japanese Patients With Hemophilia With Inhibitors
• Individual Dose Adjustment of Oral Busulfan Using a Test Dose in Hematopoietic Stem Cell Transplantation
• Molecular Cloning, Genomic Organization, Promoter Activity, and Tissue-Specific Expression of the Mouse Ryudocan Gene^1
• 生理的抗血栓分子のノックアウトマウス解析
• 教育シンポジウム:がんの遺伝子診断 PCRを用いた遺伝子診断の原理と応用-血友病Bを例にして-
• Interferon-α treatment of acute lymphoblastic leukemia relapse after unrelated bone marrow transplantation
• Granulocyte colony-stimulating factor-combined marrow-ablative chemotherapy and autologous blood cell transplantation for the treatment of patients with acute myelogenous leukemia in first remission
• Long-term Follow-up of 14 Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia following Autologous Bone Marrow Transplantation in First Complete Remission
• A new marrow T cell depletion method using anti-CD6 monoclonal antibody-conjugated magnetic beads and its clinical application for prevention of acute graft-vs.-host disease in allogeneic bone marrow transplantation: results of a phase I-II trial
• Impact of Cytogenetics on Outcome of Stem Cell Transplantation for Acute Myeloid Leukemia in First Remission : A Large-Scale Retrospective Analysis of Data from the Japan Society for Hematopoietic Cell Transplantation
• Quality of Life in Adult Patients After Stem Cell Transplantation
• Superior Efficacy of MMCP Regimen Compared with VMCP and MMPP Regimens in the Treatment of Multiple Myeloma
• Posttreatment Nadir M-Protein Level Is a Stronger Discriminator of Survival Following Plateau Attainment Than Is Percent Reduction in M-Protein in Patients With IgG Myeloma
• 先天性凝固阻止因子欠乏症(antithrombin, protein C, protein S 欠損症)
• Successful treatment using tacrolimus ointment for cutaneous graft-versus-host disease
• 血栓性素因部会 : 血栓性素因・プロテインS欠乏症/欠損症をめぐる最近の話題
• 血液凝固亢進状態の抗凝固療法
• Low-Dose Cyclosporin A with Short-Term Methotrexate for Graft-versus-Host Disease Prophylaxis in Allogeneic Bone Marrow Transplantation from Human Leukocyte Antigen-Identical Siblings : A Prospective Phase II Study in Japanese Patients
• Twenty Years' Experience in Allogeneic Hematopoietic Stem Cell Transplantation for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Nagoya Blood and Marrow Transplantation Group
• Severe hemophilia A in a Japanese female caused by an F8-intron 22 inversion associated with skewed X chromosome inactivation
• Classic Polyarteritis Nodosa Presenting Rare Clinical Manifestations in a Patient with Hemophilia A
• AT/DS併用によるエンドトキシン誘発臓器傷害の改善効果 : Antithrombin/danaparoid sodium の抗凝固薬としての位置付け
• Identification of the regulatory elements of the human von Willebrand factor for binding to platelet GPIb. Importance of structural integrity of the regions flanked by the CYS1272-CYS1458 disulfide bond
• Identification of six novel MYH9 mutations and genotype-phenotype relationships in autosomal dominant macrothrombocytopenia with leukocyte inclusions
• Identification of plasma antibody epitopes and gene abnormalities in Japanese hemophilia a patients with factor VIII inhibitor
• Optimization of the Oxidative Folding Reaction and Disulfide Structure Determination of Multiple-Cystine Peptides
• Modifications Associated with Use of the Benzyloxymethyl Group on Histidine
• Chemical Synthesis of Human β-Defensin (hBD)-1,2,3 and 4 : Optimization for Folding Reduced hBDs into a Native Conformation
• Synthesis and Disulfide Structure Determination of Muscarinic Toxin 3
• Synthesis of Amyloid β-Peptides by Employing a Convergent Solid-Phase Approach Performed in a Mixture of Chloroform and Phenol
• Synthesis and Disulfide Structure Determination of Kurtoxin, a T-type Calcium Channel Blocker
• Synthesis of Prokineticin 2 by Solid-Phase Approach Performed in a Chloroform-Phenol Mixed Solvent
• Synthesis of Human Leptin Employing a Combined Solid-Phase and Solution Approach
• Optimization of Segment Condensation Reactions of Sparingly Soluble Protected Peptides in Chloroform-Phenol Mixed Solvent
• Side Reaction Associated with Use of N^in-Cyclohexyloxy- carbonyl (Hoc) Group for Tryptophans during HF Deprotection
• Synthesis of Muscarinic Toxin 1 and 7 Possessing High Specificity for Muscarinic Acetylcholine Receptor Subtype
• Amino Acid Deletion Products Resulting from Incomplete Deprotecion of the Boc Group during Solid-Phase Peptide Synthesis
• Synthesis of Amyloid β-Peptides in Solution : Chloroform- Phenol Mixed Solvent Is Essential for Segment Condensation of Sparingly Soluble Protected Peptides
• New Powerful Solvent System, A Mixture of Chloroform and Phenol, for Segment Condensation of Sparingly Soluble Protected Petides
• Total Synthesis of Aequorea Green Fluorescent Protein
• Immune response of post-transplant peripheral lymphocytes against the patient pre-B cell line, NAGL-1
• Effect of Depolymerized Holothurian Glycosaminoglycan (DHG) on the Activation of Factor VIII and Factor V by Thrombin
• Recovery of Normal Hematopoiesis after Severe Bone Marrow Aplasia Induced by Interferon-α in a Patient with Chronic Myelogenous Leukemia
• Overexpression of the Wilms' tumor gene WT1 in primary thyroid cancer
• Wilms Tumor Gene Peptide-Based Immunotherapy for Patients with Overt Leulemia from Myelodysplastic Syndrome (MDS) or MDS with Myelofibrosis
• Overexpression of the Wilms' tumor gene WT1 in colorectal adenocarcinoma
• 血友病の遺伝子異常と遺伝子診断
• Novel Synthesized Trimannose Conjugate Induces Endocytosis and Expression of Immunostimulatory Molecules in Monocytic Leukemia Cells
• Genetic Abnormalities of Bernard-Soulier Syndrome
• Retrospective study of inhibitor formation in Japanese hemophiliacs
• Early treatment of CMV antigenemia with ganciclovir for prevention of fatal CMV disease in patients receiving marrow from HLA-matched unrelated donors
• Efficient Induction of Pptide - Specific Cytotoxic T Lymphocytes by LPS - Activated Spleen Cells
• Synthesis of Marinostatin, an Ester-Linked Protein Protease Inhibitor from the Marine Bacterium Pseudoalteromonas sagamiensis
• Suppression of Side Reactions during Final Deprotection Employing a Strong Acid
• 東北地方における血友病インヒビター調査のまとめ
• Interferon-α and zidovudine for relapsed/refractory adult T cell leukemia/lymphoma : case reports of Japanese patients
• Virus-Associated Hemophagocytic Syndrome Caused by Pandemic Swine-Origin Influenza A (H1N1) in a Patient After Unrelated Bone Marrow Transplantation
• 抗Xa薬 (凝固制御) -- (抗凝固薬の新展開)
• エストロゲンによるProtein S産生抑制
• ヘパラン硫酸プロテオグリカン・Ryudocanノックアウトマウスの作製・解析
• 日本人の血栓性素因、特にプロテインS欠損症を中心に
• 血栓性素因の病因と病態
• 新規抗凝固薬
• von Willebrand病に合併した未破裂脳動脈瘤に対してコイル塞栓術を行った１例：症例報告
• 新規血栓性素因・アンチトロンビン抵抗性遺伝子異常
• Anticoagulant therapy for hyper coagulation state
• Gene analysis of the congenital thrombophilia –present and future–
• エストロゲンによる Protein S 産生抑制

もっと見る 閉じる

スポンサーリンク